/IQVIA%20sign%20on%20the%20building%20in%20Montreal%2C%20Quebec%20By%20JHVEPhoto.jpeg)
With a market capitalization of $42.5 billion, IQVIA Holdings Inc. (IQV) is a leading global provider of clinical research services, healthcare analytics, and technology solutions for the life sciences industry. Headquartered in Durham, North Carolina, the company helps pharmaceutical and biotechnology companies accelerate drug development, conduct clinical trials, analyze healthcare data, and commercialize innovative therapies.
The company is ready to release its FY2026 Q3 earnings before the market opens on Tuesday, Oct. 27. Ahead of the event, analysts expect IQVIA to report a profit of $2.95 per share on a diluted basis, up 8.1% year over year from $2.73 per share in the year-ago quarter. The company has exceeded consensus estimates in each of the four trailing quarters.
